methylprednisolone and Affective Disorders, Psychotic

methylprednisolone has been researched along with Affective Disorders, Psychotic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rizvi, A; Shaan, F; Sharma, G	1
Beck, RW; Chrousos, GA; Cleary, PA; Kattah, JC	1

Trials

1 trial(s) available for methylprednisolone and Affective Disorders, Psychotic

Article	Year
Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA, 1993, Apr-28, Volume: 269, Issue:16 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Affective Disorders, Psychotic; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Optic Neuritis; Pancreatitis; Prednisone	1993

Other Studies

1 other study(ies) available for methylprednisolone and Affective Disorders, Psychotic

Article	Year
Cotard syndrome in Tumefactive Multiple Sclerosis- A case report. Asian journal of psychiatry, 2018, Volume: 34 Topics: Adult; Affective Disorders, Psychotic; Brain Diseases; Delusions; Depressive Disorder, Major; Female; Glucocorticoids; Humans; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Psychotropic Drugs; Syndrome; Treatment Outcome	2018

Article

Year

Cotard syndrome in Tumefactive Multiple Sclerosis- A case report.

Asian journal of psychiatry, 2018, Volume: 34

Topics: Adult; Affective Disorders, Psychotic; Brain Diseases; Delusions; Depressive Disorder, Major; Female; Glucocorticoids; Humans; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Psychotropic Drugs; Syndrome; Treatment Outcome

2018